top of page
Dr Ashleigh Bhanjan

Shining a Light on the Future : The Promise of Low-Level Laser Therapy in Neurological Healthcare, 2024

Updated: Apr 9

Low-Level Laser Therapy (LLLT) is a non-invasive treatment that uses low-power laser beams to stimulate healing and reduce pain. It has shown promise in various medical applications, including neurological conditions.


The future of healthcare using LLLT holds significant potential for growth and advancements in the next decade.


Since the introduction of PBMT in my clinical practice, I have witnessed first hand patients with conditions such as chronic pain syndromes, fibromyalgia, post covid syndrome, trigeminal neuralgia, and neurodegenerative disorders such as Parkinsons disease (improved motor scores, that show no progression on UPDRS scale), including dementia (improved cognitive scores, MMSE score, Improves brain perfusion on SPECT brain scans)





Advantages of Low-Level Laser Therapy


LLLT has been effective in managing a range of conditions, such as chronic pain, nociceptive pain reduction, and weight loss. In neurorehabilitation, LLLT has broadened its medical applications to include diseases such as stroke, myocardial infarction, and degenerative or traumatic brain disorders.


Studies have shown that LLLT can increase ATP levels, improve circulation, and reduce brain damage, making it a promising treatment for neurological diseases.





Early Treatment in Neurological Conditions


The use of LLLT in neurological conditions, such as stroke and traumatic brain injury (TBI), has shown neuroprotective effects and the potential to reduce brain damage and recovery times.


Additionally, LLLT has been observed to increase ATP levels and improve circulation in various neurological pathologies, indicating its potential for early intervention in neurological diseases.





Future Prospects of Low-Level Laser Therapy


As research and technological advancements continue to unfold, LLLT is poised to revolutionize the healthcare industry and improve the lives of patients.


The global LLLT market is expected to grow significantly, indicating a positive outlook for the future of this therapy.



In conclusion, the future of healthcare using Low-Level Laser Therapy holds great promise, especially in neurological conditions.


With its potential for early intervention, neuroprotective effects, and the expected growth in the LLLT market, this therapy is likely to play a significant role in the next decade.

References















Comentarios


bottom of page